These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1143005)

  • 1. Blockade of the systemic and renal vascular actions of angiotensisn II with the 1-sar, 8-ala analogue in the rat.
    Ishikawa I; Hollenberg NK
    Life Sci; 1975 Jul; 17(1):121-9. PubMed ID: 1143005
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of indomethacin, 6-hydroxydopamine, saralasin, and hemorrhage on renal hemodynamics.
    Fischer R; Ikeda S; Sarma JS; Bing RJ
    J Clin Pharmacol; 1977 Jan; 17(1):5-12. PubMed ID: 833339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral and neurogenic factors in two-kidney renovascular hypertension.
    de la Riva IJ; Basso N; Kurnjek ML; Taquini AC
    Arch Int Physiol Biochim; 1980 May; 88(2):137-46. PubMed ID: 6159837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of renin and angiotensin in renovascular hypertension in man.
    Fagard R; Amery A; Billiet L; Joossens JV; Lijnen P; Reybrouck T
    Acta Clin Belg; 1979; 34(3):130-9. PubMed ID: 506622
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin II increases uterine vascular resistance in pregnant and nonpregnant rabbits.
    Cohen DM; Steinberger SJ; Swan JF; Disalvo J
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):597-601. PubMed ID: 193121
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood flow alteration induced by saralasin or sodium nitroprusside in rats.
    Miller ED; Delaney TJ
    Anesthesiology; 1981 Mar; 54(3):199-203. PubMed ID: 7469102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II blockade in congestive heart failure.
    Turini GA; Brunner HR; Ferguson RK; Rivier JL; Gavras H
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):166-76. PubMed ID: 686905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
    J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin on stroke volume and regional blood flow and resistance.
    Krasney JA
    Am J Physiol; 1968 Dec; 215(6):1454-61. PubMed ID: 4301938
    [No Abstract]   [Full Text] [Related]  

  • 16. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of angiotensin II blockade by saralasin (1-Sar-8-Ala-angiotensin II) in normal man.
    Ibsen H; Kappelgaard AM; Nielsen MD; Giese J
    Eur J Clin Pharmacol; 1978 Nov; 14(3):171-6. PubMed ID: 729612
    [No Abstract]   [Full Text] [Related]  

  • 18. Separation of peripheral and central cardiovascular actions of angiotensin II.
    Kooner JS; May CN; Peart S; Mathias CJ
    Am J Physiol; 1997 Dec; 273(6):H2620-6. PubMed ID: 9435595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.
    Baylis C; Collins RC
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F308-14. PubMed ID: 3511733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.